900000000000531004~TARGETCOMPONENT~789220007
6011000124106~MAPTARGET~Q73.8
447562003~MAPRULE~TRUE
447562003~MAPADVICE~ALWAYS L90.8
6011000124106~MAPTARGET~L90.1
6011000124106~MAPRULE~IFA 402899000 | Anetoderma following varicella (disorder) |
6011000124106~MAPPRIORITY~7
6011000124106~MAPADVICE~ALWAYS L90.8
6011000124106~MAPPRIORITY~4
6011000124106~MAPADVICE~IF SCHWENINGER-BUZZI ANETODERMA CHOOSE L90.1 | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPADVICE~IF EXOSTOSIS, ANETODERMA, BRACHYDACTYLY TYPE E SYNDROME CHOOSE Q78.6 | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPRULE~IFA 110983008 | Schweninger-Buzzi anetoderma |
6011000124106~MAPADVICE~MAP SOURCE CONCEPT CANNOT BE CLASSIFIED WITH AVAILABLE DATA
6011000124106~MAPADVICE~IF ANETODERMA FOLLOWING VARICELLA CHOOSE L90.8 | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPRULE~IFA 733416004 | Exostosis, anetoderma, brachydactyly type E syndrome |
6011000124106~MAPTARGET~
6011000124106~MAPCATEGORYID~447638001
6011000124106~MAPTARGET~Q78.6
6011000124106~MAPGROUP~1
6011000124106~MAPGROUP~2
6011000124106~MAPTARGET~L90.2
6011000124106~MAPPRIORITY~8
6011000124106~MAPADVICE~IF EXOSTOSIS, ANETODERMA, BRACHYDACTYLY TYPE E SYNDROME CHOOSE Q73.8 | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPTARGET~L93.1
900000000000508004~ACCEPTABILITYID~900000000000549004
6011000124106~MAPADVICE~IF DRUG-INDUCED ANETODERMA CHOOSE T50.905? | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | EPISODE OF CARE INFORMATION NEEDED | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPRULE~IFA 403503008 | Lupus erythematosus-associated anetoderma |
6011000124106~MAPTARGET~A53.9
447562003~MAPGROUP~1
6011000124106~MAPADVICE~IF EXOSTOSIS, ANETODERMA, BRACHYDACTYLY TYPE E SYNDROME CHOOSE Q82.8 | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPTARGET~Q82.8
6011000124106~MAPRULE~IFA 402952006 | Anetoderma secondary to syphilis (disorder) |
447562003~CORRELATIONID~447561005
6011000124106~MAPRULE~IFA 403503008 | Lupus erythematosus-associated anetoderma (disorder) |
6011000124106~MAPCATEGORYID~447637006
900000000000509007~ACCEPTABILITYID~900000000000548007
900000000000508004~ACCEPTABILITYID~900000000000548007
6011000124106~MAPRULE~IFA 402952006 | Anetoderma secondary to syphilis |
6011000124106~MAPRULE~IFA 110982003 | Jadassohn-Pellizzari anetoderma (disorder) |
447562003~MAPPRIORITY~1
6011000124106~MAPRULE~IFA 403671004 | Drug-induced anetoderma (disorder) |
447562003~MAPCATEGORYID~447637006
6011000124106~MAPTARGET~B01.89
6011000124106~MAPRULE~OTHERWISE TRUE
6011000124106~MAPPRIORITY~5
900000000000497000~MAPTARGET~X50Ca
447562003~MAPTARGET~L90.8
6011000124106~MAPCATEGORYID~447639009
6011000124106~MAPADVICE~IF ANETODERMA FOLLOWING VARICELLA CHOOSE B01.89 | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPADVICE~IF JADASSOHN-PELLIZZARI ANETODERMA CHOOSE L90.2 | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPRULE~IFA 403671004 | Drug-induced anetoderma |
6011000124106~MAPRULE~IFA 402899000 | Anetoderma following varicella |
6011000124106~MAPPRIORITY~1
6011000124106~MAPADVICE~IF ANETODERMA SECONDARY TO SYPHILIS CHOOSE A53.9 | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
900000000000490003~VALUEID~723278000
6011000124106~MAPPRIORITY~6
6011000124106~MAPRULE~IFA 110982003 | Jadassohn-Pellizzari anetoderma |
6011000124106~CORRELATIONID~447561005
6011000124106~MAPTARGET~T50.905?
6011000124106~MAPRULE~IFA 110983008 | Schweninger-Buzzi anetoderma (disorder) |
6011000124106~MAPADVICE~ALWAYS L90.8 | DESCENDANTS NOT EXHAUSTIVELY MAPPED
6011000124106~MAPRULE~TRUE
6011000124106~MAPGROUP~3
6011000124106~MAPADVICE~IF DRUG-INDUCED ANETODERMA CHOOSE L90.8 | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPPRIORITY~3
6011000124106~MAPTARGET~L90.8
900000000000509007~ACCEPTABILITYID~900000000000549004
6011000124106~MAPADVICE~IF ANETODERMA SECONDARY TO SYPHILIS CHOOSE L90.8 | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPPRIORITY~2
6011000124106~MAPADVICE~IF LUPUS ERYTHEMATOSUS-ASSOCIATED ANETODERMA CHOOSE L93.1 | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
See more
See less